BioMarin Pharmaceutical's IPO

BioMarin Pharmaceutical raised a round of funding on July 24, 1999. Investors include Public.

BioMarin (NASDAQ: BMRN) develops and commercializes biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that address currently unmet medical needs; suggest a…

Articles about BioMarin Pharmaceutical's IPO: